| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.47e-04 | 46 | 53 | 3 | GO:0004715 | |
| Domain | TyrKc | 9.71e-05 | 88 | 51 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 9.71e-05 | 88 | 51 | 4 | IPR020635 | |
| Domain | PROTEIN_KINASE_TYR | 1.42e-04 | 97 | 51 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.42e-04 | 97 | 51 | 4 | IPR008266 | |
| Domain | Pkinase_Tyr | 4.22e-04 | 129 | 51 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 5.45e-04 | 138 | 51 | 4 | IPR001245 | |
| Domain | THIOL_PROTEASE_CYS | 2.28e-03 | 26 | 51 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 2.46e-03 | 27 | 51 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 2.46e-03 | 27 | 51 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 2.64e-03 | 28 | 51 | 2 | IPR000169 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23076336 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 12906867 | ||
| Pubmed | 8.08e-06 | 83 | 53 | 4 | 11114734 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 10022914 | ||
| Pubmed | Seventy-five genetic loci influencing the human red blood cell. | 1.19e-04 | 62 | 53 | 3 | 23222517 | |
| Pubmed | 1.77e-04 | 71 | 53 | 3 | 33541421 | ||
| Pubmed | The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome. | 2.05e-04 | 14 | 53 | 2 | 29568343 | |
| Pubmed | 2.70e-04 | 16 | 53 | 2 | 30579834 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.18e-04 | 861 | 53 | 7 | 36931259 | |
| Pubmed | 4.70e-04 | 21 | 53 | 2 | 20708005 | ||
| Pubmed | 6.16e-04 | 24 | 53 | 2 | 33722704 | ||
| Pubmed | Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. | 1.24e-03 | 138 | 53 | 3 | 28786561 | |
| Pubmed | 1.39e-03 | 36 | 53 | 2 | 15717329 | ||
| Coexpression | GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP | 1.26e-06 | 171 | 53 | 6 | M7105 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.26e-06 | 192 | 53 | 5 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.89e-06 | 199 | 53 | 5 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.83e-05 | 147 | 53 | 4 | 4ba9a86ab7033688a9a2a2dc84c001a49af835b4 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.22e-05 | 152 | 53 | 4 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.31e-05 | 153 | 53 | 4 | 489228ab81c3ae339a53a9da6c2a1c1b6ac3f84b | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 3.75e-05 | 158 | 53 | 4 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 162 | 53 | 4 | 8ed9149ff53b285591354057055d072b203a47c8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.13e-05 | 162 | 53 | 4 | 8278dccdb139396ede34b83b02ebce837f2489d6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-05 | 162 | 53 | 4 | 7a05b05a33e1309fb5c0a8171db105ae68491815 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | 1b9b4e165121b08ef15a93fca6bea875cae69f19 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.34e-05 | 173 | 53 | 4 | c25f24d7b672c9686d31ebc8d263042282f520fd | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 176 | 53 | 4 | 2e3f25a338842384517656d05776a52cbfc62b52 | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 176 | 53 | 4 | 0823088bc6b19c7ad784d83c2ccdfae80611afab | |
| ToppCell | mild_COVID-19-NK_CD56bright|mild_COVID-19 / disease group, cell group and cell class (v2) | 6.23e-05 | 180 | 53 | 4 | d8b418edd807a51c0b5f4018b8b478dcc65892a7 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 189 | 53 | 4 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.52e-05 | 189 | 53 | 4 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-05 | 189 | 53 | 4 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.68e-05 | 190 | 53 | 4 | 112706d64ee73b55dcf76f33ca064ab1fc6ce87f | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.68e-05 | 190 | 53 | 4 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 190 | 53 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-05 | 192 | 53 | 4 | 2ec132a1740e865e7cc0f82ffd4772d43f7ac086 | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-05 | 192 | 53 | 4 | 3792c53b5d4b759573e1c7bb89ef9b654c9cbfcd | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-05 | 192 | 53 | 4 | 64022a47dccd7966777f6741d1c68e298f37ca9d | |
| ToppCell | 3'-Distal_airway-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-05 | 192 | 53 | 4 | f67a88bd039944d3d7a5a4a9f2e053985075155c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-NK-NK-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.99e-05 | 192 | 53 | 4 | 6d7dd35869d86c3e991a61e17825053a3bfab44d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.32e-05 | 194 | 53 | 4 | 5cd72330c9d9bb21b6c9d5d35085eade101486d1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.32e-05 | 194 | 53 | 4 | b6328575eedb19e0ad7f4d03041672f3dc146da0 | |
| ToppCell | PBMC-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.32e-05 | 194 | 53 | 4 | b16b96e42ea9734731342d4c41ff1711bd149462 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 567fcf882c8612356946240843525b786f3c8dbe | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.00e-05 | 198 | 53 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | medial-Endothelial-Lymphatic-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.00e-05 | 198 | 53 | 4 | 41983d405215b974044e2e9e6c212b134336a6fe | |
| ToppCell | medial-2-Endothelial-Lymphatic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.00e-05 | 198 | 53 | 4 | e4274584512a72270087a1ab104fab449a2f83bc | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|T_cell / Lineage, cell class and subclass | 9.00e-05 | 198 | 53 | 4 | 6773c6043ef4a3d9e9700330b6386431ee66abdc | |
| ToppCell | medial-Endothelial-Lymphatic|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.00e-05 | 198 | 53 | 4 | 1760fede363544bc0fa2e22fe36aff522abd2525 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | Sigmoid-Dendritic_cell-cDC1|Dendritic_cell / Region, Cell class and subclass | 9.36e-05 | 200 | 53 | 4 | 09deb831fc2c8a8867cc850f3aa094a5e48489ff | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-B|COVID-19_Mild / Disease, condition lineage and cell class | 9.36e-05 | 200 | 53 | 4 | 11b51dfca161342d92126e0a83d10864348ba3ef | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 6.00e-06 | 195 | 53 | 6 | 4734_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; HL60; HT_HG-U133A | 6.00e-06 | 195 | 53 | 6 | 2475_DN | |
| Drug | Lincomycin hydrochloride [859-18-7]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.36e-06 | 197 | 53 | 6 | 7411_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.36e-06 | 197 | 53 | 6 | 3239_DN | |
| Drug | 2-Chloropyrazine [14508-49-7]; Down 200; 35uM; HL60; HT_HG-U133A | 6.74e-06 | 199 | 53 | 6 | 6148_DN | |
| Drug | Harpagoside [19210-12-9]; Up 200; 8uM; MCF7; HT_HG-U133A | 6.74e-06 | 199 | 53 | 6 | 7355_UP | |
| Drug | Gallamine triethiodide [65-29-2]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 6215_UP | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; HL60; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 2163_DN | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 2770_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; HL60; HT_HG-U133A | 9.00e-05 | 195 | 53 | 5 | 2432_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; HL60; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 2473_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Down 200; 12uM; HL60; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 3113_DN | |
| Drug | Hexamethonium dibromide dihydrate [55-97-0]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 4965_DN | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 5449_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 5610_DN | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 5459_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 9.44e-05 | 197 | 53 | 5 | 1013_UP | |
| Drug | Clopamide [636-54-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 3220_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 3935_DN | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 9.44e-05 | 197 | 53 | 5 | 2309_DN | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 4568_DN | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 4505_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 3236_DN | |
| Drug | Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 5266_DN | |
| Drug | Trimethadione [127-48-0]; Down 200; 28uM; HL60; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 2486_DN | |
| Drug | Vitexin [3681-93-4]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 2155_DN | |
| Drug | Pirenperone [ 75444-65-4]; Down 200; 10.2uM; HL60; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 2455_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 5703_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 9.67e-05 | 198 | 53 | 5 | 4194_DN | |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 3082_DN | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 7330_DN | |
| Drug | Zomepirac sodium salt [64092-48-4]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 6815_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 5601_DN | |
| Drug | sodium 4-phenylbutyrate; Down 200; 1000uM; MCF7; HG-U133A | 9.90e-05 | 199 | 53 | 5 | 408_DN | |
| Drug | Iobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 6002_DN | |
| Drug | Morantel tartrate [26155-31-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 9.90e-05 | 199 | 53 | 5 | 7250_DN | |
| Disease | neuroticism measurement | 1.94e-05 | 909 | 50 | 9 | EFO_0007660 | |
| Disease | retinal vasculature measurement | 2.32e-04 | 517 | 50 | 6 | EFO_0010554 | |
| Disease | Osteoarthritis of hip | 5.24e-04 | 20 | 50 | 2 | C0029410 | |
| Disease | anxiety | 5.57e-04 | 223 | 50 | 4 | EFO_0005230 | |
| Disease | serum alanine aminotransferase measurement | 6.22e-04 | 869 | 50 | 7 | EFO_0004735 | |
| Disease | response to venlafaxine | 8.23e-04 | 25 | 50 | 2 | EFO_0006328 | |
| Disease | apolipoprotein B measurement | 8.63e-04 | 663 | 50 | 6 | EFO_0004615 | |
| Disease | testosterone measurement | 1.27e-03 | 1275 | 50 | 8 | EFO_0004908 | |
| Disease | phosphatidylcholine measurement | 1.37e-03 | 284 | 50 | 4 | EFO_0010226 | |
| Disease | Mitral valve prolapse | 1.71e-03 | 36 | 50 | 2 | HP_0001634 | |
| Disease | cortical surface area measurement | 1.78e-03 | 1345 | 50 | 8 | EFO_0010736 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 1.90e-03 | 38 | 50 | 2 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | immature reticulocyte measurement | 2.11e-03 | 40 | 50 | 2 | EFO_0803545 | |
| Disease | systemic lupus erythematosus | 2.23e-03 | 799 | 50 | 6 | MONDO_0007915 | |
| Disease | myocardial infarction | 2.92e-03 | 350 | 50 | 4 | EFO_0000612 | |
| Disease | serum non-albumin protein measurement | 3.26e-03 | 361 | 50 | 4 | EFO_0004568 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 5.14e-03 | 63 | 50 | 2 | EFO_0001645, EFO_0004792 | |
| Disease | susceptibility to cold sores measurement | 5.47e-03 | 65 | 50 | 2 | EFO_0008402 | |
| Disease | MYELODYSPLASTIC SYNDROME | 5.80e-03 | 67 | 50 | 2 | C3463824 | |
| Disease | dentures | 6.31e-03 | 70 | 50 | 2 | EFO_0010078 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LWTCPEDREPDSSTD | 281 | Q8WTP8 | |
| LWPADSSCRREAVSP | 311 | Q96MC4 | |
| DSCWPDPSRNTELAF | 171 | P54793 | |
| SESDHFRCRDRLSPW | 6 | Q6ZU80 | |
| SATWDFPLPSCRADD | 186 | Q7Z408 | |
| ASWDFPVPICRAEDA | 226 | Q7Z407 | |
| SERPLWDTSLRAPSC | 491 | O43299 | |
| WDTSLRAPSCLEAFR | 496 | O43299 | |
| IPSTWRCFATDPDGL | 466 | Q16671 | |
| RDRLWSSPAFSPTCP | 1276 | Q7Z401 | |
| LECPPFQTERRESWS | 586 | Q96JH8 | |
| RRDNVCSLSWPSAEP | 46 | P31275 | |
| CWRTDPLDRPTFSVL | 836 | Q12866 | |
| TSRAEVCPWEFETPA | 1166 | Q5T848 | |
| PSICVRDPVSDWFES | 406 | O95544 | |
| DSRWSRDPLYRDDPC | 516 | Q6PJ61 | |
| YAPRLDDSDCPRSWT | 406 | Q9UMF0 | |
| RLSSRSDAWDCFQPG | 716 | Q9Y5G2 | |
| LEFCPDTLDWRAAEP | 146 | Q30201 | |
| RREDALSSEGCLWPS | 81 | Q969W9 | |
| FGWPDSLDCARLPTR | 131 | O00144 | |
| EEPWSPCSARFITDF | 401 | O75173 | |
| DSCPRWDTLPTECRD | 296 | Q6ZSI9 | |
| PSSPLCWREESSFAA | 46 | Q8WWV6 | |
| ECWRSRPEERPTFEF | 471 | P51451 | |
| SEEPEESVPFSCDWR | 121 | P56202 | |
| SPAERAPERRDVCWS | 1126 | Q9NS15 | |
| VWRDCLPPSLRASDA | 141 | Q8NHY5 | |
| WHESDSFTENAPCRP | 111 | Q9NWQ4 | |
| PFFNDRPWRRATAES | 321 | P11047 | |
| TLMTRCWDYDPSDRP | 656 | Q14289 | |
| EDPRRPDTSFLWFTS | 2016 | O75923 | |
| ATDARRAFPCWDEPA | 181 | P55786 | |
| SLALSFAPWCDERCR | 176 | Q96B33 | |
| DCWDSERSDSLSPPR | 181 | Q9UPQ0 | |
| DWLACTSARSFPRSE | 216 | Q96L03 | |
| PTETFSWPDVRELCS | 1041 | A1L390 | |
| SWVCPRPLARSDSEN | 186 | Q6ZUM4 | |
| ECWRSSPEERPSFAT | 461 | Q9H3Y6 | |
| RRGAPWLFCDRESSP | 1231 | Q8IY92 | |
| RACAPPSEGLLFRWD | 291 | Q7Z7M1 | |
| RSFFDPTSQHRDWCP | 416 | Q86WB0 | |
| SSWEPRRASTAFCPP | 656 | O00562 | |
| RDCRSPVDPWAAASP | 16 | P55822 | |
| WDCSFPRDASRLEPS | 471 | Q9H6E5 | |
| TLLDCTRHDWAPPRF | 341 | O15014 | |
| PDAFSCSWERLHELR | 261 | A8MPS7 | |
| RFTRDDPWLSSCEEV | 141 | Q9UJW8 | |
| CLSDEFRLRDSSSPW | 126 | Q15326 | |
| HDWAPPRFCESPTSD | 411 | Q9ULD9 | |
| SWSESRAGERRFPCP | 46 | Q9P2Y4 | |
| DAPDTDWCDSIPARD | 136 | Q12836 | |
| ASSETLRCEAPRWFP | 161 | Q7Z7D3 | |
| CFDPKEDRWSLRSPA | 461 | Q6PF15 |